Showing results (41-50 of 75) with videos related to
Sort By:
Pageof 8
Plos One|December 2, 2016
Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National SurveyKim Steegen, Sergio Carmona, Michelle Bronze, et al.The Lancet. Infectious Diseases|August 30, 2016
Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan AfricaSeth C Inzaule, Pascale Ondoa, Trevor Peter, et al.BMC Pediatrics|November 23, 2011
Utility of clinical parameters to identify HIV infection in infants below ten weeks of age in South Africa: a prospective cohort studyHeather B Jaspan, Landon Myer, Shabir A Madhi, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 6, 2019
The Utility of the Lipoprotein-Associated Phospholipase A<sub>2</sub> (Lp-PLA<sub>2</sub>) Assay in Detecting Abnormalities in Lipid Metabolism and Cardiovascular Risk in an HIV-Infected South African CohortElizabeth S Mayne, Hellen Moabi, Diederick E Grobbee, et al.Plos One|July 30, 2010
FOXP3 expression is upregulated in CD4T cells in progressive HIV-1 infection and is a marker of disease severityMelinda S Suchard, Elizabeth Mayne, Victoria A Green, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 26, 2017
Multidisciplinary Point-of-Care Testing in South African Primary Health Care Clinics Accelerates HIV ART Initiation but Does Not Alter Retention in CareWendy S Stevens, Natasha M Gous, William B MacLeod, et al.The Journal of Infectious Diseases|March 10, 2012
Perspectives on introduction and implementation of new point-of-care diagnostic testsKara M Palamountain, Jeff Baker, Elliot P Cowan, et al.Plos One|April 13, 2012
HIV-1 phenotypic reverse transcriptase inhibitor drug resistance test interpretation is not dependent on the subtype of the virus backboneMichelle Bronze, Kim Steegen, Carole L Wallis, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2012
Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitorsJessica H Brehm, Dianna L Koontz, Carole L Wallis, et al.Scientific Reports|February 15, 2023
Cross-municipality migration and spread of tuberculosis in South AfricaAbdou M Fofana, Harry Moultrie, Lesley Scott, et al.Pageof 8